VYEPTI

Lundbeck Canada Inc🇨🇦 Health Canada

Approval Id: 29cbe5c3e8ea2cce
Drug Approval Canada Name: VYEPTI
Product Name: VYEPTI
Status: Marketed
Status Date: 2022-08-17
Original Market Date: 2022-08-17
Din: 02510839
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 28:32.12
Atc Original: N02CD05 EPTINEZUMAB
Atc Name: n 02 cd 05
Aig Number: 0162703001
Company Name: Lundbeck Canada Inc
Company Address: 2600 Alfred-Nobel, Suite 400, St-Laurent, Quebec, Canada, H4S 0A9
Company Detail Path: /organization/lundbeck-canada-inc

EPTINEZUMAB

100 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

29cbe5c3e8ea2cce

Type

Standard